Markets cheered by third dose of good news over Covid vaccine trials
Oxford/AstraZeneca jab will be cheaper than rivals and easier to distribute
Full Article
Markets cheered by third dose of good news over Covid vaccine trials
FT.com
0 shares
1 views
You might like
Related news coverage
SII to seek emergency use authorisation for AstraZeneca COVID-19 vaccine in 2 weeks: Adar Poonawalla
Mid-Day
The Serum Institute of India (SII) will seek emergency use authorisation for the AstraZeneca Covid 19 vaccine in about two..
-
Russia to produce Sputnik V COVID-19 vaccine in India
Mid-Day
-
Bharat Biotech's COVID-19 vaccine 'Covaxin' commences phase-3 trial at AIIMS
Mid-Day
-
AstraZeneca manufacturing error clouds Oxford vaccine study results
Mid-Day
-
1 crore healthcare workers to receive COVID-19 vaccine in first phase: Report
Mid-Day
Advertisement
More coverage
Russia's Sputnik V COVID-19 vaccine claimed to be 95 per cent effective
Mid-Day
Russia's Sputnik V vaccine has been found to be more than 95 per cent effective against Covid-19 in the second interim analysis of..
-
Trials show third COVID-19 vaccine is cheaper, effective
Mid-Day
-
US stocks close higher on vaccine optimism as Biden taps ex-Fed Chair Yellen as Treasury secretary
Proactive Investors
-
Wall Street mixed as vaccine optimism cheers traders, tech struggles
Proactive Investors
-
US benchmarks start the week higher as more vaccine optimism cheers traders
Proactive Investors